(EMSN) EMS-CHEMIE HOLDING - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0016440353
EMSN EPS (Earnings per Share)
EMSN Revenue
EMSN: High-Performance Polymers, Specialty Chemicals, Adhesives, Fibers, Coatings
EMS-CHEMIE HOLDING AG is a leading global player in the production of high-performance polymers and specialty chemicals, serving various industries including automotive, electronics, and consumer goods. Its High Performance Polymers segment produces high-performance polyamide granulate, while its Specialty Chemicals segment develops and manufactures a range of products, including fibers, adhesives, and coatings. With a presence in the United States, Europe, Asia, and internationally, the company has established itself as a significant supplier to diverse markets, including optic and packaging.
Analyzing the companys position, we can see that EMS-CHEMIE HOLDING AG has a strong track record, having been founded in 1936 and headquartered in Domat/Ems, Switzerland. As a subsidiary of EMESTA HOLDING AG, it benefits from a stable ownership structure. The companys product portfolio is diversified, catering to various industries, which can provide a degree of resilience against market fluctuations. With a global footprint, EMS-CHEMIE HOLDING AG is well-positioned to capitalize on emerging trends and growth opportunities in the high-performance polymers and specialty chemicals sectors.
Based on the available
Forecasting the stocks performance, we can anticipate that EMS-CHEMIE HOLDING AG will continue to benefit from its diversified product portfolio and global presence. Assuming the companys high-performance polymers and specialty chemicals businesses continue to grow, driven by increasing demand from key industries, we can expect the stock to potentially move towards its 52-week high of 763.98 CHF. However, this will depend on various factors, including market conditions and the companys ability to maintain its profitability. Based on the current technical and fundamental data, a potential target price could be around 650-680 CHF, representing a 7-12% increase from the current price. Nevertheless, this forecast is subject to the inherent uncertainties of the market and the companys future performance.
Additional Sources for EMSN Stock
EMSN Stock Overview
Market Cap in USD | 17,724m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception |
EMSN Stock Ratings
Growth Rating | -47.9 |
Fundamental | 72.2 |
Dividend Rating | 1.0 |
Rel. Strength | -18.8 |
Analysts | - |
Fair Price Momentum | 513.61 CHF |
Fair Price DCF | 945.88 CHF |
EMSN Dividends
Dividend Yield 12m | 1.06% |
Yield on Cost 5y | 0.95% |
Annual Growth 5y | -26.93% |
Payout Consistency | 71.3% |
Payout Ratio | 64.7% |
EMSN Growth Ratios
Growth Correlation 3m | 30.1% |
Growth Correlation 12m | -88.6% |
Growth Correlation 5y | -72.5% |
CAGR 5y | -3.10% |
CAGR/Max DD 5y | -0.07 |
Sharpe Ratio 12m | -0.21 |
Alpha | -26.44 |
Beta | 0.310 |
Volatility | 21.37% |
Current Volume | 10k |
Average Volume 20d | 11.1k |
As of June 26, 2025, the stock is trading at CHF 590.00 with a total of 9,967 shares traded.
Over the past week, the price has changed by -0.25%, over one month by -5.68%, over three months by -3.52% and over the past year by -18.92%.
Yes, based on ValueRay´s Fundamental Analyses, EMS-CHEMIE HOLDING (SW:EMSN) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 72.16 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EMSN is around 513.61 CHF . This means that EMSN is currently overvalued and has a potential downside of -12.95%.
EMS-CHEMIE HOLDING has no consensus analysts rating.
According to our own proprietary Forecast Model, EMSN EMS-CHEMIE HOLDING will be worth about 564.4 in June 2026. The stock is currently trading at 590.00. This means that the stock has a potential downside of -4.34%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 663.1 | 12.4% |
Analysts Target Price | - | - |
ValueRay Target Price | 564.4 | -4.3% |